BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 28670477)

  • 1.
    Meijer TG; Naipal KA; Jager A; van Gent DC
    Future Sci OA; 2017 Jun; 3(2):FSO190. PubMed ID: 28670477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing a Microfluidic Tumor Slice Culture Platform to Study Drug Response.
    Komar ZM; van Gent DC; Chakrabarty S
    Curr Protoc; 2023 Mar; 3(3):e693. PubMed ID: 36912175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of drug responses of mini patient-derived xenografts in mice for predicting cancer patient clinical therapeutic response.
    Zhang F; Wang W; Long Y; Liu H; Cheng J; Guo L; Li R; Meng C; Yu S; Zhao Q; Lu S; Wang L; Wang H; Wen D
    Cancer Commun (Lond); 2018 Sep; 38(1):60. PubMed ID: 30257718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models.
    Tsai S; McOlash L; Palen K; Johnson B; Duris C; Yang Q; Dwinell MB; Hunt B; Evans DB; Gershan J; James MA
    BMC Cancer; 2018 Mar; 18(1):335. PubMed ID: 29587663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Organotypic Models of Lung Cancer.
    Pomerenke A
    Curr Top Microbiol Immunol; 2021; 430():161-181. PubMed ID: 29423618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 3D Culture as a Clinically Relevant Model for Personalized Medicine.
    Fong ELS; Toh TB; Yu H; Chow EK
    SLAS Technol; 2017 Jun; 22(3):245-253. PubMed ID: 28277923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using Organotypic Tissue Slices to Investigate the Microenvironment of Pancreatic Cancer: Pharmacotyping and Beyond.
    Weitz JR; Tiriac H; Hurtado de Mendoza T; Wascher A; Lowy AM
    Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
    Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
    Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Cancer Medicine: An Organoid Approach.
    Aboulkheyr Es H; Montazeri L; Aref AR; Vosough M; Baharvand H
    Trends Biotechnol; 2018 Apr; 36(4):358-371. PubMed ID: 29366522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor organoids: From inception to future in cancer research.
    Yang L; Yang S; Li X; Li B; Li Y; Zhang X; Ma Y; Peng X; Jin H; Fan Q; Wei S; Liu J; Li H
    Cancer Lett; 2019 Jul; 454():120-133. PubMed ID: 30981763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review.
    Kashaninejad N; Nikmaneshi MR; Moghadas H; Kiyoumarsi Oskouei A; Rismanian M; Barisam M; Saidi MS; Firoozabadi B
    Micromachines (Basel); 2016 Jul; 7(8):. PubMed ID: 30404302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ex vivo organotypic culture system of precision-cut slices of human pancreatic ductal adenocarcinoma.
    Misra S; Moro CF; Del Chiaro M; Pouso S; Sebestyén A; Löhr M; Björnstedt M; Verbeke CS
    Sci Rep; 2019 Feb; 9(1):2133. PubMed ID: 30765891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organotypic Slice Cultures as Preclinical Models of Tumor Microenvironment in Primary Pancreatic Cancer and Metastasis.
    Braun R; Lapshyna O; Eckelmann S; Honselmann K; Bolm L; Ten Winkel M; Deichmann S; Schilling O; Kruse C; Keck T; Wellner U; Bronsert P; Brandenburger M
    J Vis Exp; 2021 Jun; (172):. PubMed ID: 34251366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 3D in vitro model of patient-derived prostate cancer xenograft for controlled interrogation of in vivo tumor-stromal interactions.
    Fong EL; Wan X; Yang J; Morgado M; Mikos AG; Harrington DA; Navone NM; Farach-Carson MC
    Biomaterials; 2016 Jan; 77():164-72. PubMed ID: 26599623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Organotypic 3D Models of the Ovarian Cancer Tumor Microenvironment.
    Watters KM; Bajwa P; Kenny HA
    Cancers (Basel); 2018 Aug; 10(8):. PubMed ID: 30096959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An
    van de Merbel AF; van der Horst G; van der Mark MH; van Uhm JIM; van Gennep EJ; Kloen P; Beimers L; Pelger RCM; van der Pluijm G
    Front Oncol; 2018; 8():400. PubMed ID: 30333957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Organotypic tumor slice cultures provide a versatile platform for immuno-oncology and drug discovery.
    Sivakumar R; Chan M; Shin JS; Nishida-Aoki N; Kenerson HL; Elemento O; Beltran H; Yeung R; Gujral TS
    Oncoimmunology; 2019; 8(12):e1670019. PubMed ID: 31741771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
    Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioengineering-inspired three-dimensional culture systems: Organoids to create tumor microenvironment.
    Saglam-Metiner P; Gulce-Iz S; Biray-Avci C
    Gene; 2019 Feb; 686():203-212. PubMed ID: 30481551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Melanoma Immunotherapy and Precision Medicine in the Era of Tumor Micro-Tissue Engineering: Where Are We Now and Where Are We Going?
    Varrone F; Mandrich L; Caputo E
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.